Yvette L. Kasamon, Ephraim J. Fuchs, Javier Bolaños-Meade, Mary S. Leffell^*, Marianna Zahurak^*, Gary L. Rosner^*, Jonathan D. Powell, Richard F. Ambinder, Richard J. Jones and Leo Luznik^*

Johns Hopkins University, Baltimore, MD

Aaron T. Gerds, MD, MS¹, Matt E. Kalaycio, MD², Kwang Woo Ahn, PhD^3,4*, Zhen-Huan Hu, MPH^3*, Edwin P. Alyea, MD⁵, Uday R. Popat, MD⁶, Ronald M. Sobecks, MD⁷ and Wael Saber, MD, MS⁸

¹Leukemia Program, Cleveland Clinic, Cleveland, OH
²Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
⁴Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI
⁵Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁸CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

William Arcese, MD¹, Raffaella Cerretti, MD^2*, Laura Cudillo, MD^1*, Gottardo De Angelis, MD^1*, Benedetta Mariotti, MD^1*, Adriano Venditti, MD³, Francesco Buccisano, MD³, Maria Cantonetti, MD^3*, Ilaria Mangione, MD^1*, Marco Andreani, PhD^4*, Manuela Testi, PhD^4*, Paolo De Fabritiis, MD^5*, Teresa Dentamaro, MD^5*, Luca Cupelli, MD^5*, Andrea Tendas, MD^5*, Giuseppe Avvisati, MD⁶, Maria Cristina Tirindelli, MD^6*, Ombretta Annibali, MD, PHD^6*, Andrea Mengarelli, MD^7*, Francesco Marchesi, MD^7*, Atelda Romano, MD^7*, Anna Chierichini, MD^8*, Barbara Anaclerico, MD^9*, Agostino Tafuri, MD¹⁰, Antonella Ferrari, MD^11*, Virginia Naso, MD^11*, Silvia Miccichè, MSc^1*, Fabio Di Piazza, MSc^1*, Francesco Lo Coco, MD^3*, Sergio Amadori, MD³ and Alessandra Picardi, MD^1*

¹Stem Cell Transplant Unit, University Tor Vergata, Rome, Italy
²Stem Cell Transplant Unit, Tor Vergata University, Rome, Italy
³Hematology, University Tor Vergata, Rome, Italy
⁴International Center for Transplantation in Thalassemia and Sickle Cell Anemia.Mediterranean Institute of Hematology. Policlinico Tor Vergata., Rome, Italy
⁵Hematology, S. Eugenio Hospital, Rome, Italy
⁶Hematology, University Campus Bio Medico, Rome, Italy
⁷Hematology, Regina Elena National Cancer Institute, Rome, Italy
⁸Hematology, S. Giovanni Addolorata Hospital, Rome, Italy
⁹Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
¹⁰Hematology, Sapienza AO Sant'Andrea, Rome, Italy
¹¹Hematology, S. Andrea Hospital, Rome, Italy

Betul Oran, MD¹, Rima M Saliba, Ph.D^1*, Yudith Carmazzi^2*, Elizabeth J. Shpall, MD¹, Katayoun Rezvani, M.D., PhD¹, Marcos De Lima, MD³, Marcelo Fernández-Viña^4*, Richard E. Champlin, MD¹ and Kai Cao, MS, MD^5*

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Laboratory Medicine, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Hematology and Oncology, University Hospitals Seidman Cancer Center, Cleveland
⁴Department of Pathology, Stanford School of Medicine, Palo Alto
⁵Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Xiao-Ying Qin^1,2,3*, Yu Wang^1,2,3*, Guo-Xuan Li^1,2,3*, Yazhen Qin^1,3,4*, Lan-Ping Xu^1,2,3*, Fengrong Wang^1,2,3*, Huan Chen^1,2,3*, Wei Han^1,2,3*, Jing-Zhi Wang^1,2,3*, Xiao-Hui Zhang^1,2,3*, Ying-Jun Chang^1,2,3*, Kaiyan Liu^2,3,5, Zheng-Fan Jiang^6* and Xiao-jun Huang^1,2,3

¹Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China
²Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
³Peking-Tsinghua Center for Life Sciences, Beijing, China
⁴Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁵Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
⁶State Key Laboratory of Protein and Plant Gene Research, Key Laboratory of Cell Proliferation and Differentiation of the Ministry of Education, School of Life Sciences, Peking University, Beijing, China; Peking University-Tsinghua University Joint Center, Beijing, China

Natasha Kekre, MD, FRCPC¹, Francisco J Marquez-Malaver, RN^2*, Dolores Caballero, MD^3*, Jl Piñana, MD^4*, Albert Esquirol, MD^5*, Robert J. Soiffer, MD⁶, Monica Cabrero, MD^7*, MJ Terol^4*, Rodrigo Martino, MD, PhD⁸, Joseph H. Antin, MD⁹, L Lopez Corral^7*, Carlos Solano¹⁰, Philippe Armand, MD, PhD¹¹ and Jose A. Perez-Simon, M.D., PhD¹²

¹Dana Farber Cancer Institute, Boston, MA
²Dept. Hematology, Instituto de Biomedicina de Sevilla (IBIS)/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain
³Hospital Universitario de Salamanca, Salamanca, Spain
⁴Dept. of Hematology/Oncology, Hospital Clinico Universitario, Valencia, Spain
⁵Clinical Hematology Service, Hospital de la Santa Creu i Sant Pau, Jose Carreras Leukemia Research Institute., Barcelona, Spain
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁷Hematology Service, University Hospital, Instituto Biosanitario de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain
⁸Hospital Santa Creu i Sant Pau, Barcelona, Spain
⁹Dana-Farber Cancer Institute, Massachusetts General, Children’s Hospital, Boston, MA
¹⁰Hematology Department, Hospital Clínico Universitario La Fe, Valencia, Spain
¹¹Dana-Farber Cancer Institute, Boston, MA
¹²Dept. of Hematology, Hospital Universitario Virgen del Rocío, Sevilla, Spain

Sabine Kayser, MD¹, Axel Benner^2*, Christian Thiede, MD³, Uwe Martens, MD⁴, Josef Huber^4*, Peter Stadtherr^1*, Johannes W.G. Janssen, PhD^5*, Christoph Röllig, MD^6*, Michael J. Uppenkamp, MD⁷, Tilmann Bochtler, MD^8*, Ute Hegenbart, MD^9*, Gerhard Ehninger, MD¹⁰, Anthony D. Ho, MD¹¹, Peter Dreger, MD⁹ and Alwin Kraemer, MD^1*

¹Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany
²German Cancer Research Center, Heidelberg, Germany
³Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany
⁴Cancer Center Heilbronn-Franken, Heilbronn, Germany
⁵University Hospital of Heidelberg, Heidelberg, Germany
⁶Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
⁷Department of Oncology, Hospital of Ludwigshafen, Ludwigshafen, Germany
⁸Amyloidosis Center, University Hospital Heidelberg, Heidelberg, Germany
⁹Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
¹⁰Medical Dept. 1, University Hospital TU Dresden, Dresden, Germany
¹¹Dept. Med. V, University Hospital Heidelberg, Heidelberg, Germany

Fotios V. Michelis, MD, PhD¹, Vikas Gupta, MD, FRCP, FRCPath², Mei-Jie Zhang, PhD^3,4*, Hai-Lin Wang, MPH^3*, Marcos de Lima, MD^5*, Hanna Jean Khoury, MD^6*, Brenda M Sandmaier, MD^7* and Wael Saber, MD, MS³

¹Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
²Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
³CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI
⁵Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, WI
⁶Emory University Hospital, Atlanta, GA
⁷Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Scott R. Solomon, MD¹, Connie Sizemore^1*, Xu Zhang, PhD^2*, Melhem Solh, MD¹, Lawrence E. Morris, MD¹, H. Kent Holland, MD¹ and Asad Bashey, MD, PhD¹

¹The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
²Department of Mathematics and Statistics, Georgia State University, Atlanta, GA

Issa F. Khouri¹, Rima M Saliba, Ph.D^1*, Celina Ledesma^1*, Elias J. Jabbour, MD², Francesco Turturro, MD³, Gheath Alatrash, DO, PhD⁴, Sairah Ahmed, MD¹, Betul Oran, MD¹, Krina K Patel¹, Amanda Olson^5*, David Marin, MD^1*, Uday R. Popat, MD¹, Tina S Suki^6*, Jeffrey L. Jorgensen, MD, PhD⁷, L. Jeffrey Medeiros, MD⁷ and Alison M Gulbis^8*

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁵Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX

Philipp G. Hemmati, MD¹, Theis Terwey, MD^1*, Il-Kang Na, MD^2*, Christian Jehn, MD^1*, Lam G. Vuong, PhD^1*, Philipp le Coutre, MD¹, Bernd Dörken, MD^1* and Renate Arnold, MD³

¹Department of Hematology and Oncology, Charité University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany
²Hematology and Oncology, Charité University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany
³Department of Hematology and Oncology, Charite University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany

Prathima Anandi, MD^1*, Xin Tian, PhD^2*, Puja D. Chokshi^1*, Noelle Watters^3*, Sawa Ito^1*, Minoo Battiwalla, MD, MS¹ and Austin John Barrett, MD, FRCP, FRCPath¹

¹Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
²Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
³Office of Biostatistics Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Nadja Jaekel, MD^1*, Song-Yau Wang, MD^2*, Rainer Krahl, Ph.D^3*, Karolin Hubert^4*, Susann Schulze, MD^5*, Rayk Stengel, PhD^6*, Melanie Schneider^6*, Martin Roskos, PhD^6*, Dietger Niederwieser, MD² and Haifa Kathrin Al-Ali, MD^4*

¹Hematology and Oncology, University of Leipzig, Leipzig, Germany
²University Hospital of Leipzig, Leipzig, Germany
³Department of Hematology and Oncology, University Hospital of Leipzig, Leipzig, Germany
⁴University of Leipzig, Leipzig, Germany
⁵Hematology and Oncology, University Hospital of Leipzig, Leipzig, Germany
⁶Oncoscreen Synlab, Jena, Germany

Adriana Balduzzi, MD¹, Jean-Hugues Dalle, MD, PhD², Arjan C Lankester, MD, PhD³, Isaac Yaniv, MD⁴, Akif Yesilipek, MD^5*, Petr Sedlacek, MD, PhD^6*, Marianne Ifversen, MD^7*, Sabina Sufliarska, MD^8*, Marc B Bierings, MD PhD⁹, Jacek Wachowiak, Prof MD PhD^10*, Jacek Toporski, MD, PhD¹¹, Ulrike Poetschger^12*, Evgenia Glogova^12*, Ingeborg Hirsch, BS^12* and Christina Peters, MD, PhD^13*

¹Clinica Pediatrica Universita' degli Studi di Milano Bicocca, Ospedale San Gerardo, Monza, Italy
²Pediatric Hematology Immunology, Robert Debre Hospital, Paris, France
³Dept. of Pediatrics, Leiden University Medical Center, Leiden, Netherlands
⁴Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Tel Aviv, Israel
⁵Bahçesehir University School of Medicine Goztepe Medicalpark Hospital, Ä°stanbul, Turkey
⁶University Hospital Motol, Prague, Czech Republic
⁷Department of Pediatrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Rigshospitalet, Denmark
⁸Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia
⁹Department of Hematology and Immunology, Wilhelmina Children's Hospital, Utrecht, Netherlands
¹⁰Department of Pediatrics Oncology, Hematology and Transplantation, University of Medical Sciences, Poznan, Poland
¹¹Dept. of Hematology/Oncology, University Hospital, Lund, Sweden
¹²Children’s Cancer Research Institute, Vienna, Austria
¹³Stem Cell Transplantation Unit, St. Anna Children's Hospital, Vienna, Austria

Francesco Spina, MD^1*, Serena Camilla Dalto, MD^1*, Simonetta Viviani, MD^2*, Chiara De Philippis, MD^1,3*, Anna Dodero, MD^4*, Lucia Farina, MD, PhD^5*, Vittorio Montefusco^6* and Paolo Corradini, MD^1,3

¹Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
²Istituto Nazionale dei Tumori, Milan, Italy
³Chair of Hematology, Universita' degli Studi di Milano, Milan, Italy
⁴Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
⁵Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁶Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Eric Segal, BS^1*, Michael Martens, MS^2*, Hai-Lin Wang, MPH^3*, Ruta Brazauskas, PhD^4*, Daniel Weisdorf, MD⁵, Brenda M. Sandmaier, MD⁶, Marcos J de Lima, MD⁷, H. Jean Khoury, MD⁸ and Wael Saber, MD, MS³

¹Medical College of Wisconsin, Milwaukee, WI
²Department of Biostatistics, Medical College of Wisconsin, Milwaukee, WI
³CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
⁵Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
⁶Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
⁷Department of Medicine, University Hospital Case Medical Center, Cleveland, OH
⁸Department of Hematology and Medical Oncology, Emory University, Atlanta, GA

Reid W. Merryman, MD^1*, Haesook T. Kim, PhD^2*, Pier Luigi Zinzani, MD, PhD³, Carmelo Carlo-Stella, MD⁴, Stephen M Ansell^5*, Ahmad S. Halwani, MD⁶, Miguel-Angel Perales, MD⁷, Vincent T. Ho, MD⁸, Joseph H. Antin, MD⁸, Jerome Ritz, MD⁹, Robert J. Soiffer, MD⁸ and Philippe Armand, MD, PhD¹⁰

¹Department of Medicine, Brigham and Women's Hospital, Boston, MA
²Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston, MA
³Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy
⁴Humanitas Clinical & Research Center, Milan, Italy
⁵Mayo Clinic, Rochester, MN
⁶Huntsman Cancer Institute, Salt Lake City, UT
⁷Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁹Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
¹⁰Dana-Farber Cancer Institute, Boston, MA

Moreno Festuccia, MD^1,2*, Kelsey Baker^3*, Theodore A Gooley, PhD^3*, Brenda M. Sandmaier, MD¹, Joachim Deeg, MD¹, Brent L Wood, MD, PhD⁴, Min Fang, MD, PhD^4* and Bart Lee Scott, MD¹

¹Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
²University of Torino, Torino, Italy
³Clinical Statistics Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Seattle Cancer Care Alliance, Seattle, WA

Fotios V. Michelis, MD, PhD¹, Hans A. Messner, M.D./Ph.D¹, Naheed Alam, MBBS, MD¹, Vikas Gupta, MD, MRCP, FRCPath², Dennis Dong Hwan Kim, MD, PhD³, John Kuruvilla, MD², Anna Lambie, RN NP^1*, Auro Viswabandya, MD, DM¹ and Jeffrey H. Lipton, MD, PhD⁴

¹Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
²Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
³Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
⁴Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Xavier Poiré, MD^1*, Myriam Labopin, MD^2,3*, Johan Maertens, MD, PhD^4*, Ibrahim Yakoub-Agha, MD, PhD⁵, Didier Blaise, MD, PhD⁶, Norbert Ifrah, MD, PhD⁷, Gerard Socie⁸, Tobias Gedde-Dhal^9*, Nicolaas PM Schaap¹⁰, Jan Cornelissen, MD, PhD¹¹, Noel Milpied¹², Jaime Sanz, MD,¹³, Lucienne Michaux^14*, Jordi Esteve, MD, PhD¹⁵, Mohamad Mohty, MD, PhD^16,17 and Arnon Nagler, MD, MSc^3,18

¹Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
²Department of Hematology and Cell Therapy, Saint Antoine Hospital, Paris, France
³EBMT, Acute Leukemia Working Party, Paris, France
⁴Department of Hematology, University Hospital Gasthuisberg Leuven, Leuven, Belgium
⁵Hematology, CHU de Lille, Lille, France
⁶Programme de Transplantation et Therapie Cellulaire, Institut Paoli Calmettes, Marseille, France
⁷Hematology Department, University Hospital, Angers, France
⁸St-Louis Hospital, Paris, France
⁹Rikshospitalet, Oslo, Norway
¹⁰Department of Hematology, Radboud University Medical Centre, Nijmegen, Netherlands
¹¹Department of Hematology, Erasmus MC-Daniel den Hoed Cancer Centre, Rotterdam, Netherlands
¹²CHU Bordeaux, Hematology, Pessac, France
¹³Hospital Universitario la Fe, Valencia, Spain
¹⁴Center for Human Genetics, KU Leuven, Leuven, Belgium
¹⁵Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
¹⁶Hematology Dpt, Hopital Saint-Antoine, University UPMC, INSERM, Paris, France
¹⁷department of hematology and cell therapy, hopital Saint-Antoine, EBMT Acute Leukemia Working Party and Registry, Hospital Saint-Antoine, Paris University, Paris, France
¹⁸Division of Hematology and Bone Marrow Transplantation, Division of Hematology & Bone Marrow Transplantation, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel, Israel Transplantation, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel, Tel Hashomer, Israel

Claudio G Brunstein, MD¹, Corey S Cutler, MD, MPH², Todd E. DeFor, MS^3*, Thomas R. Spitzer, MD⁴, Nelli Bejanyan, MD¹, Alfred L. Garfall, MD⁵, Michael R. Verneris, MD³, Yi-Bin Chen, MD⁶, Erica Warlick, MD⁷, Haesook T. Kim, PhD^8*, Jeffrey S. Miller, MD¹, Joseph H. Antin, MD⁹, Daniel J. Weisdorf, MD^10*, Robert J Soiffer, MD¹¹, John E Wagner, MD¹² and Karen K. Ballen, MD⁶

¹Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
²Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³Adult and Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN
⁴Massachusetts General Hospital, Boston
⁵Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁶Massachusetts General Hospital, Boston, MA
⁷University of Minnesota, Minneapolis, MN
⁸Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
⁹Dana-Farber Cancer Institute, Massachusetts General, Children’s Hospital, Boston, MA
¹⁰Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
¹¹Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
¹²Department of Pediatrics, University of Minnesota, Minneapolis, MN

Kinjal Parikh, M.D.^1*, Lekha Mikkilineni, M.D.^1*, Fern Martin, M.D.^1*, Dolores Grosso, R.N., CRNP, DNP^2*, Benjamin Leiby, PhD^3*, Onder Alpdogan, M.D.², Matthew Carabasi, M.D.², Margaret Kasner, M.D.², Thomas R. Klumpp, M.D.², Ubaldo Martinez Outschoorn, MD², Manish Sharma, M.D.², Mark Weiss, MD², John L. Wagner, M.D.², Neal Flomenberg, M.D.² and Joanne Filicko-O'Hara, M.D.²

¹Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA
²Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
³Department of Pharmacology & Experimental Therapeutics,, Jefferson Medical College, Philadelphia

Hiroaki Shimizu, M.D., PhD.^1,2*, Takayuki Saitoh, MD, PhD^3*, Shinichiro Okamoto⁴, Yoshinobu Kanda, MD, PhD⁵, Heiwa Kanamori⁶, Satoshi Takahashi, M.D., Ph.D.⁷, Kazuteru Ohashi, MD, FACP⁸, Kensuke Usuki, MD, Ph.D.^9*, Chiaki Nakaseko, MD, PhD¹⁰, Makoto Onizuka, MD, PhD¹¹, Toru Sakura^12*, Moritaka Goto^13*, Shingo Yano¹⁴, Shin Fujisawa^15*, Reiko Watanabe, MD, PhD^16*, Nobuyuki Aotsuka, MD^17*, Jun Taguchi^18*, Naoto Tomita¹⁹, Hisashi Wakita, MD^17* and Yasuhito Nannya, MD, PhD^20*

¹Oncology Center, Gunma University Hospital, Gunma, Japan
²Kanto Study Group for Cell Therapy, Tokyo, Japan
³Department of Laboratory Science, Gunma University Graduate School of Health Scienses, Gunma, Japan
⁴Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
⁵Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan
⁶Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
⁷Division of Molecular Therapy, Advanced Clinical Research Center, Institute of Medical Sciece, Univ. of Tokyo, Tokyo, Japan
⁸Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
⁹Deptartment of Hematology, NTT Medical Center Tokyo, Tokyo, Japan
¹⁰Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan
¹¹Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
¹²Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma, Japan
¹³Division of Hematology, Tokyo Medical University Hospital, Tokyo, Japan
¹⁴Jikei University, Tokyo, Japan
¹⁵Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
¹⁶Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan
¹⁷Departmet of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan
¹⁸Hematology, Shizuoka Red Cross Hospital, Shizuoka, Japan
¹⁹Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
²⁰Hematology and Oncology, Tokyo University, Tokyo, Japan

Michele Pohlen, MD^1*, Christoph Groth, MD^1*, Tim Sauer, MD^1*, Dennis Görlich^2*, Rolf Mesters, MD^1*, Christoph Schliemann, MD^1*, Georg Lenz, MD^3*, Carsten Müller-Tidow, MD^4*, Thomas Büchner, MD^5*, Wolfgang E Berdel, MD⁶ and Matthias Stelljes, MD¹

¹Department of Medicine A, University of Muenster, Muenster, Germany
²Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany
³Translational Oncology, University of Muenster, Muenster, Germany
⁴Department of Medicine IV, Hematology and Oncology, University of Halle, Halle, Germany
⁵Department of Medicine A, University of Münster, Münster, Germany
⁶Department of Medicine A, University Hospital Münster, Muenster, Germany

Jin Shang^1*, Jing Sun, MD², Zhiping Fan^1*, Fen Huang^1*, Yu Zhang, MD^1*, Qianli Jiang, MD, PhD^1*, Hongsheng Zhou^1* and Qifa Liu, MD¹

¹Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
²Department of Hematology, NanFang Hospital, Southern Medical University, Guangzhou, China

Satyajit Kosuri, MD¹, Tara F. Wolff, MS, NP-BC^2*, Courtney Byam, BS, CHTC^3*, Emily Lauer, BS, BA^1*, Yeon Yoo, BS^1*, Miguel-Angel Perales, MD¹, Sergio A. Giralt, MD¹, Andromachi Scaradavou, MD³, Doris M Ponce, MD¹ and Juliet N. Barker, MBBS (Hons)¹

¹Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY

Melhem Solh, MD¹, Xu Zhang, PhD^2*, Katelin Connor^3*, Stacey Brown, B.A.^1*, H. Kent Holland, MD¹, Lawrence E. Morris, MD¹, Scott R. Solomon, MD⁴ and Asad Bashey, MD, PhD¹

¹The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
²Department of Mathematics and Statistics, Georgia State University, Atlanta, GA
³The Blood and Marrow Transplant Group of Georgia at Northside Hospital, Atlanta, GA
⁴Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA

Fabio Guolo, MD^1*, Federica Galaverna, MD^2*, Paola Minetto, MD^1*, Livia Giannoni, MD^1*, Chiara Ghiggi, PhD^3*, Marino Clavio, MD^1*, Carmen Di Grazia, MD^2*, Anna Maria Raiola, MD^2*, Nicoletta Colombo, PhD^1*, Raffaella Grasso, PhD^1*, Maurizio Miglino, PhD^1*, Adalberto Ibatici, MD^3*, Roberto Massimo Lemoli, MD¹, Marco Gobbi, MD^1* and Andrea Bacigalupo, MD²

¹Chair of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy
²Second Division of Hematology and Bone Marrow Transplantation, IRCCS AOU San Martino-IST, Genoa, Italy
³First Division of Hematology and Bone Marrow Transplantation, IRCCS AOU San Martino-IST, Genoa, Italy

Anish Puliyayil Nair, MD, DM¹, Patricia A. Walker, MBBS, FRACP, FRCPA², Anna Kalff, MBBS, FRACP, FRCPA³, Krystal Bergin, MBBS^4*, Sharon Avery, MBBS (Hons), FRACP, FRCPA⁵, David J. Curtis, M.D., Ph.D.⁶, Sushrut S. Patil, FRACP, FRCPA¹, Jenny Muirhead^7*, Tongted Phomoonna^7*, Daniela Klarica, RN^8* and Andrew Spencer⁹

¹Haematology, ALFRED HEALTH, Melbourne, Australia
²The Alfred Hosp., Melbourne, Australia
³Department of Clinical Haematology, Alfred Hospital-Monash University, Melbourne, Australia
⁴Myeloma Research Group, Alfred Health-Monash University, Melbourne, Australia
⁵Department of Haematology, Alfred Hospital, Melbourne, Australia
⁶Australian Centre For Blood Diseases, Monash University, Melbourne, Australia
⁷ALFRED HEALTH, PRAHRAN PO BOX 315, Australia
⁸Malignant Haematology and Stem Cell Transplantation Service, Alfred Health, Melbourne, Australia
⁹Clinical Haematology & BMT, Alfred Hospital, Melbourne, Australia

Amy E. DeZern, MD, MHS¹, Donna Dorr, RN, MSN, AOCN^2*, Leo Luznik, MD^3*, Javier Bolanos-Meade, MD⁴, Christopher Gamper, MD, PhD^5*, Heather J. Symons, MD, MHS⁶, Kenneth R. Cooke, MD², Richard J. Jones Sr., MD⁷ and Robert A. Brodsky, MD⁸

¹The Johns Hopkins School of Medicine, Baltimore, MD
²The Johns Hopkins University School of Medicine, Baltimore, MD
³Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
⁴Hematologic Malignancies, Johns Hopkins University, Baltimore, MD
⁵Oncology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD
⁶Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
⁷Sidney Kimmel Comprehensive Cancer Cancer, Baltimore, MD
⁸Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Marius Bill, MD PhD^*, Madlen Jentzsch, MD^*, Luba Schuhmann^*, Juliane Grimm^*, Maria Knyrim^*, Laura Katharina Schmalbrock, MD^*, Schubert Karoline^*, Michael Cross, PhD^*, Vladan Vucinic, MD^*, Georg-Nikolaus Franke, MD^*, Wolfram Poenisch, MD^*, Gerhard Behre, MD^*, Thoralf Lange, MD^*, Dietger Niederwieser, MD and Sebastian Schwind, MD

Hematology and Oncology, University of Leipzig, Leipzig, Germany

Federica Galaverna, MD^1*, Fabio Guolo, MD^2*, Daniela Pende, MD^3*, Alida Dominietto, MD^4*, Raffaella Meazza, PhD^5*, Michela Falco, PhD^6*, Carmen Di Grazia, MD^1*, Anna Maria Raiola, MD^1*, Anna Ghiso, MD^7*, Riccardo Varaldo, MD^8*, Francesca Gualandi, MD^9*, Carlo Marani, MD^10*, Maria Teresa van Lint, MD^11*, Roberto Massimo Lemoli, MD², Marco Gobbi, MD^2*, Paola Minetto, MD^2* and Andrea Bacigalupo, MD^11,12

¹Second Division of Hematology and Bone Marrow Transplantation, IRCCS AOU San Martino-IST, Genoa, Italy
²Chair of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy
³Department of Immunology, IRCCS AUO San Martino-IST, Genova, Italy
⁴Second division of Hematology and Bone Marrow Transplantation, IRCCS AOU San Martino-IST, Genoa, Italy
⁵Department of Immunology, IRCCS AOU San Martino-IST, IRCCS AOU San Martino-IST, Genoa, Italy
⁶Giannina Gaslini Hospital, Genova, Italy
⁷Secondo Division of Hematology and Bone Marrow Transplantation,IRCCS AOU San Martino-IST, IRCCS AOU San Martino-IST, Genoa, Italy
⁸Second division of Hematology and Bone Marrow Transplantation,IRCCS AOU San Martino-IST, IRCCS AOU San Martino-IST, Genoa, Italy
⁹Second division of Hematology and Bone Marrow Transplantation,IRCCS AOU San Martino-IST, IRCCS San Martino-IST, Genoa, Italy
¹⁰Second Division od Hematology and Bone Marrow Transplantation,IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy
¹¹Second Division of Hematology and Bone Marrow Transplantation,IRCCS AOU San Martino-IST, IRCCS San Martino-IST, Genoa, Italy
¹²Policlinico Gemelli, Catholic University, Rome, Italy

Roberto Crocchiolo, M.D., Ph.D.^1*, Barbara Sarina, MD^2*, Stefania Bramanti, MD^2*, Lucio Morabito, MD^2*, Andrea Rimondo^2*, Monica Balzarotti^3*, Massimo Magagnoli^2*, Carmelo Carlo-Stella, MD⁴, Armando Santoro, MD^5* and Luca Castagna^5*

¹Department of Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Milano, Italy
²Humanitas Clinical and Research Center, Milano, Italy
³ISTITUTO CLINICO HUMANITAS, Rozzano, Italy
⁴Hematology, Humanitas Cancer Center, rozzano, Italy
⁵Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy